Taken together, these data indicate that the CXCL9/10-CXCR3 axis is instrumental for the enhanced T cell recruitment into GBM tumors, wherein inhibition of VEGF signaling additionally creates a favorable microenvironment for T cell activation. The gene discussed is CXCL9; the disease is glioblastoma.